vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and LCNB CORP (LCNB). Click either name above to swap in a different company.
LCNB CORP is the larger business by last-quarter revenue ($23.9M vs $19.2M, roughly 1.2× Apyx Medical Corp). LCNB CORP runs the higher net margin — 23.7% vs -6.8%, a 30.5% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs 5.1%). LCNB CORP produced more free cash flow last quarter ($33.4M vs $-2.8M). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs 15.7%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
LCNB Corp is a United States-based financial holding company that operates through its national bank subsidiary, providing a full suite of retail and commercial banking products and services including deposit accounts, various loan products, wealth management, and insurance solutions primarily to individual consumers, small and medium-sized enterprises and local community organizations across regional markets in Ohio.
APYX vs LCNB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $23.9M |
| Net Profit | $-1.3M | $5.7M |
| Gross Margin | 62.6% | — |
| Operating Margin | 0.1% | 29.2% |
| Net Margin | -6.8% | 23.7% |
| Revenue YoY | 34.7% | 5.1% |
| Net Profit YoY | 71.9% | -7.6% |
| EPS (diluted) | — | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $23.9M | ||
| Q3 25 | $12.9M | $23.8M | ||
| Q2 25 | $11.4M | $22.8M | ||
| Q1 25 | $9.4M | $21.5M | ||
| Q4 24 | $14.2M | $22.7M | ||
| Q3 24 | $11.5M | $21.4M | ||
| Q2 24 | $12.1M | $19.3M | ||
| Q1 24 | $10.2M | $17.8M |
| Q4 25 | $-1.3M | $5.7M | ||
| Q3 25 | $-2.0M | $6.9M | ||
| Q2 25 | $-3.8M | $5.9M | ||
| Q1 25 | $-4.2M | $4.6M | ||
| Q4 24 | $-4.6M | $6.1M | ||
| Q3 24 | $-4.7M | $4.5M | ||
| Q2 24 | $-6.6M | $925.0K | ||
| Q1 24 | $-7.6M | $1.9M |
| Q4 25 | 62.6% | — | ||
| Q3 25 | 64.4% | — | ||
| Q2 25 | 62.3% | — | ||
| Q1 25 | 60.1% | — | ||
| Q4 24 | 63.0% | — | ||
| Q3 24 | 60.5% | — | ||
| Q2 24 | 61.7% | — | ||
| Q1 24 | 58.1% | — |
| Q4 25 | 0.1% | 29.2% | ||
| Q3 25 | -6.5% | 35.6% | ||
| Q2 25 | -22.6% | 31.6% | ||
| Q1 25 | -32.4% | 25.6% | ||
| Q4 24 | -21.4% | 32.9% | ||
| Q3 24 | -31.6% | 24.9% | ||
| Q2 24 | -45.7% | 4.9% | ||
| Q1 24 | -64.6% | 12.5% |
| Q4 25 | -6.8% | 23.7% | ||
| Q3 25 | -15.4% | 29.1% | ||
| Q2 25 | -33.2% | 26.0% | ||
| Q1 25 | -44.0% | 21.4% | ||
| Q4 24 | -32.5% | 27.0% | ||
| Q3 24 | -40.9% | 21.2% | ||
| Q2 24 | -54.0% | 4.8% | ||
| Q1 24 | -74.0% | 10.7% |
| Q4 25 | — | $0.40 | ||
| Q3 25 | — | $0.49 | ||
| Q2 25 | — | $0.41 | ||
| Q1 25 | — | $0.33 | ||
| Q4 24 | — | $0.44 | ||
| Q3 24 | — | $0.31 | ||
| Q2 24 | $-0.19 | $0.07 | ||
| Q1 24 | $-0.22 | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $21.6M |
| Total DebtLower is stronger | $37.5M | $104.4M |
| Stockholders' EquityBook value | $14.5M | $273.9M |
| Total Assets | $66.8M | $2.2B |
| Debt / EquityLower = less leverage | 2.58× | 0.38× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | $21.6M | ||
| Q3 25 | $25.1M | $35.9M | ||
| Q2 25 | $29.3M | $49.8M | ||
| Q1 25 | $31.0M | $37.7M | ||
| Q4 24 | $31.7M | $35.7M | ||
| Q3 24 | $28.0M | $39.4M | ||
| Q2 24 | $32.7M | $34.9M | ||
| Q1 24 | $37.3M | $33.0M |
| Q4 25 | $37.5M | $104.4M | ||
| Q3 25 | $37.5M | $104.7M | ||
| Q2 25 | $37.5M | $105.0M | ||
| Q1 25 | $37.5M | $104.6M | ||
| Q4 24 | $37.5M | $155.2M | ||
| Q3 24 | $37.5M | $155.7M | ||
| Q2 24 | — | $162.2M | ||
| Q1 24 | — | $162.6M |
| Q4 25 | $14.5M | $273.9M | ||
| Q3 25 | $5.8M | $269.9M | ||
| Q2 25 | $7.3M | $263.5M | ||
| Q1 25 | $10.5M | $258.7M | ||
| Q4 24 | $14.2M | $253.0M | ||
| Q3 24 | $11.0M | $253.2M | ||
| Q2 24 | $14.7M | $245.2M | ||
| Q1 24 | $20.3M | $233.7M |
| Q4 25 | $66.8M | $2.2B | ||
| Q3 25 | $57.4M | $2.2B | ||
| Q2 25 | $58.2M | $2.3B | ||
| Q1 25 | $60.2M | $2.3B | ||
| Q4 24 | $64.8M | $2.3B | ||
| Q3 24 | $60.7M | $2.3B | ||
| Q2 24 | $65.4M | $2.4B | ||
| Q1 24 | $70.7M | $2.3B |
| Q4 25 | 2.58× | 0.38× | ||
| Q3 25 | 6.41× | 0.39× | ||
| Q2 25 | 5.17× | 0.40× | ||
| Q1 25 | 3.57× | 0.40× | ||
| Q4 24 | 2.64× | 0.61× | ||
| Q3 24 | 3.40× | 0.61× | ||
| Q2 24 | — | 0.66× | ||
| Q1 24 | — | 0.70× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $34.4M |
| Free Cash FlowOCF − Capex | $-2.8M | $33.4M |
| FCF MarginFCF / Revenue | -14.6% | 140.2% |
| Capex IntensityCapex / Revenue | 1.4% | 4.0% |
| Cash ConversionOCF / Net Profit | — | 6.08× |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | $54.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $34.4M | ||
| Q3 25 | $-3.5M | $14.0M | ||
| Q2 25 | $-1.2M | $5.5M | ||
| Q1 25 | $-702.0K | $2.2M | ||
| Q4 24 | $-2.9M | $93.2M | ||
| Q3 24 | $-4.4M | $11.9M | ||
| Q2 24 | $-4.3M | $54.9M | ||
| Q1 24 | $-6.3M | $-11.9M |
| Q4 25 | $-2.8M | $33.4M | ||
| Q3 25 | $-4.1M | $13.7M | ||
| Q2 25 | $-1.5M | $5.2M | ||
| Q1 25 | $-757.0K | $2.1M | ||
| Q4 24 | $-3.2M | $89.4M | ||
| Q3 24 | $-4.6M | $10.5M | ||
| Q2 24 | $-4.6M | $53.8M | ||
| Q1 24 | $-6.4M | $-12.8M |
| Q4 25 | -14.6% | 140.2% | ||
| Q3 25 | -31.5% | 57.4% | ||
| Q2 25 | -13.2% | 23.0% | ||
| Q1 25 | -8.0% | 10.0% | ||
| Q4 24 | -22.4% | 394.0% | ||
| Q3 24 | -40.0% | 49.0% | ||
| Q2 24 | -38.0% | 278.6% | ||
| Q1 24 | -62.2% | -71.8% |
| Q4 25 | 1.4% | 4.0% | ||
| Q3 25 | 4.0% | 1.3% | ||
| Q2 25 | 2.3% | 1.0% | ||
| Q1 25 | 0.6% | 0.3% | ||
| Q4 24 | 1.7% | 16.7% | ||
| Q3 24 | 1.3% | 6.7% | ||
| Q2 24 | 2.4% | 5.9% | ||
| Q1 24 | 0.3% | 4.8% |
| Q4 25 | — | 6.08× | ||
| Q3 25 | — | 2.02× | ||
| Q2 25 | — | 0.92× | ||
| Q1 25 | — | 0.48× | ||
| Q4 24 | — | 15.23× | ||
| Q3 24 | — | 2.63× | ||
| Q2 24 | — | 59.35× | ||
| Q1 24 | — | -6.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
